First National Bank Of Omaha Eli Lilly & CO Transaction History

First National Bank Of Omaha

$1.43 Billion
Q4 2024

A detailed history of First National Bank Of Omaha transactions in Eli Lilly & CO stock. As of the latest transaction made, First National Bank Of Omaha holds 11,881 shares of LLY stock, worth $9.24 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

11,881

Previous 11,882 0.01%

Holding current value

$9.24 Million

Previous $10.5 Million 12.86%

% of portfolio

0.64%

Previous 0.71%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$727.2 - $932.06 $727 - $932	-1 Reduced 0.01%	11,881 $9.17 Million
Q3 2024 Nov 15, 2024	SELL	$772.14 - $960.02 $852,442 - $1.06 Million	-1,104 Reduced 8.5%	11,882 $10.5 Million
Q2 2024 Aug 15, 2024	SELL	$724.87 - $909.04 $2.26 Million - $2.84 Million	-3,121 Reduced 19.38%	12,986 $11.8 Million
Q1 2024 Jun 03, 2025	SELL	$592.2 - $792.28 $755,055 - $1.01 Million	-1,275 Reduced 10.73%	10,606 $8.25 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $1.69 Million - $2.27 Million	-2,859 Reduced 15.07%	16,107 $12.5 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $3.54 Million - $4.17 Million	-6,732 Reduced 26.2%	18,966 $11.1 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $3.18 Million - $4.39 Million	-7,319 Reduced 22.17%	25,698 $13.8 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $4.15 Million - $5.55 Million	-11,832 Reduced 26.38%	33,017 $15.5 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $611,630 - $718,330	-1,969 Reduced 4.21%	44,849 $15.4 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $1.11 Million - $1.29 Million	-3,455 Reduced 6.87%	46,818 $17.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $343,323 - $391,253	-1,158 Reduced 2.25%	50,273 $16.3 Million
Q2 2022 Sep 06, 2022	SELL	$278.73 - $327.27 $369,874 - $434,287	-1,327 Reduced 2.52%	51,431 $16.7 Million
Q1 2022 May 25, 2022	BUY	$234.69 - $291.66 $867,883 - $1.08 Million	3,698 Added 7.54%	52,758 $15.1 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $560,551 - $695,646	-2,493 Reduced 4.84%	49,060 $13.6 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $902,798 - $1.11 Million	-4,074 Reduced 7.32%	51,553 $11.9 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $1.16 Million - $1.5 Million	-7,068 Reduced 11.27%	55,627 $10.4 Million
Q4 2020 Feb 18, 2021	SELL	$130.46 - $172.63 $40,833 - $54,033	-313 Reduced 0.5%	62,695 $10.6 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $205,292 - $237,458	-1,404 Reduced 2.18%	63,008 $9.33 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $1.2 Million - $1.45 Million	-8,826 Reduced 12.05%	64,412 $10.6 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $155,241 - $192,144	-1,304 Reduced 1.75%	73,238 $10.2 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $347,703 - $430,662	-3,252 Reduced 4.18%	74,542 $9.8 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $266,975 - $290,400	-2,500 Reduced 3.11%	77,794 $8.7 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $943,155 - $1.1 Million	-8,513 Reduced 9.59%	80,294 $8.9 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $919,197 - $1.08 Million	-8,258 Reduced 8.51%	88,807 $11.5 Million
Q4 2018 Jan 23, 2019	BUY	$105.9 - $118.64 $10.3 Million - $11.5 Million	97,065 New	97,065 $11.2 Million
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $10.7 Million - $12 Million	-100,758 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $50,056 - $62,561	-583 Reduced 0.58%	100,758 $10.8 Million
Q2 2018 Jul 12, 2018	BUY	$75.7 - $86.88 $62,376 - $71,589	824 Added 0.82%	101,341 $8.65 Million
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $10,240 - $12,088	-138 Reduced 0.14%	100,517 $7.78 Million
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $8.25 Million - $8.85 Million	100,655	100,655 $8.5 Million

Others Institutions Holding LLY

# of Institutions

4,394

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $739B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.

Account

First National Bank Of Omaha Eli Lilly & CO Transaction History